A noninvasive method for deep-brain stimulation may be a new approach for the treatment of neuropsychiatric diseases.
Smaller plastic particles have more effects on neurons, the key information processing cells of the brain, new research from the University of Eastern Finland shows. In the study, neuronal cells were exposed to polystyrene nanoplastics at low doses to study subtle changes.
The study is published in the journal NanoImpact.
Plastic production continues to rise, despite worldwide concerns. In addition to environmental implications, there is an increasing interest in how exposure to plastics may impact human health, but our understanding is still limited. Only recently was it shown that plastics can also accumulate in the human brain.
A new breakthrough technology, co-developed by UCL scientists, that simultaneously records and manipulates neuron activity deep within the brain could transform our understanding of neural circuits and neurological conditions, such as Alzheimer’s disease and schizophrenia.
The device, known as Neuropixels Opto and researched in mice, integrates two powerful but traditionally separate techniques—electrophysiology (the study of the electrical activity of living cells) and optogenetics (combining genetics and optics to control cells). They form a single probe, enabling unprecedented insight into how individual neurons in the brain function and interact.
Published in Nature Methods, the system allows researchers to monitor the electrical activity of hundreds of neurons while also selectively activating or silencing specific cells using light.
Researchers at the Institute of Environmental Medicine (IMM), Karolinska Institutet, have identified a possible mechanism behind the spread of the aggressive brain tumor diffuse midline glioma. The study shows that the brain’s own immune cells, microglia, may contribute to the tumor’s invasive capacity by producing the protein fibronectin. The results are published in the journal Cell Death & Disease.
Diffuse midline glioma (DMG), also known as diffuse intrinsic pontine glioma (DIPG), is a rare but highly aggressive brain tumor that primarily affects children. There is currently no effective treatment, and the prognosis is very poor.
In the present study, the researchers investigated how microglia—the brain’s immune cells—are affected by tumor cells and what role they play in disease progression.
The report, titled “Pathways to Longevity”, introduces several important longevity concepts to the general reader and is another sign that the field is coming of age and entering the mainstream.
People do want to live longer
From time to time, Harvard Health Publishing issues Special Health Reports – consumer-facing, doctor-reviewed guides translating medical research for general readers. Previous reports included topics such as Alzheimer’s and heart disease. This new one, presented to the public earlier this week, is dedicated to healthy longevity. While this report, aimed mostly at curious laypeople and priced at $29, might not reveal a trove of new information to a longevity-savvy reader, it is an unmistakable sign that longevity science and the very idea of extending lifespan and healthspan are finally entering the mainstream.
A newly identified protein called GPNMB may play a major role in helping Parkinson’s disease spread through the brain. Researchers discovered that immune cells release the protein in response to damaged neurons, creating a vicious cycle that speeds up brain cell degeneration. In early experiments, antibodies that blocked GPNMB stopped the toxic process from spreading between cells.